{"id":2231,"date":"2018-06-05T10:59:00","date_gmt":"2018-06-05T02:59:00","guid":{"rendered":"https:\/\/tcr.cph.ntu.edu.31app.tw\/?p=2231"},"modified":"2022-01-22T11:08:05","modified_gmt":"2022-01-22T03:08:05","slug":"%e7%99%8c%e7%99%bb%e7%ac%ac107003%e8%99%9f%e9%80%9a%e7%9f%a5%e6%96%87-%e5%9b%a0%e6%87%89107%e5%b9%b4%e7%99%8c%e7%97%87%e7%99%bb%e8%a8%98%e5%af%a6%e5%8b%99%e4%bd%9c%e6%a5%ad%e4%b9%8b%e9%9c%80","status":"publish","type":"post","link":"https:\/\/twcr.tw\/?p=2231","title":{"rendered":"[\u764c\u767b\u7b2c107003\u865f\u901a\u77e5\u6587] \u56e0\u61c9107\u5e74\u764c\u75c7\u767b\u8a18\u5be6\u52d9\u4f5c\u696d\u4e4b\u9700\u6c42\uff0c\u8acb \u8cb4\u9662\u4f9d\u8aaa\u660e\u6bb5\u8fa6\u7406"},"content":{"rendered":"

\u4e00\u3001 \u672c\u6848\u4fc2\u4f9d\u885b\u751f\u798f\u5229\u90e8\u570b\u6c11\u5065\u5eb7\u7f72\u59d4\u8a17\u300c\u53f0\u7063\u764c\u75c7\u767b\u8a18\u5de5\u4f5c\u8a08\u756b\u300d\u8fa6\u7406\u3002<\/p>\n

\u4e8c\u3001 \u4f9d\u64da\u6700\u65b0WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2017)\u5f59\u6574\u800c\u6210\u3002\u56e02000\u5e74\u51fa\u7248\u4e4bICD-O-3\u7de8\u78bc\u4e0d\u6577\u4f7f\u7528\uff0c\u4e14\u73fe\u884c\u75c5\u7406\u5831\u544a\u6309\u6700\u65b0\u7d44\u7e54\u578b\u614b\u8a18\u8f09\uff0c\u6545\u63d0\u4f9b\u6700\u65b0\u75c5\u7406\u7d44\u7e54\u578b\u614b\u7de8\u78bc\u4f9b\u91ab\u9662\u4f7f\u7528(\u9644\u4ef6\u66f4\u65b0\u81ea\u764c\u767b107001\u865f\u901a\u77e5\u6587\u5167\u5bb9)\uff0cWHO 2017\u5e74\u65b0\u589e\u7de8\u78bc\u8acb\u65bc2017\u8a3a\u65b7\u5e74\u500b\u6848\u958b\u59cb\u9069\u7528\u3002\u6ce8\u610f\u4e8b\u9805\u5982\u4e0b\uff1a<\/p>\n

(1) \u65b0\u589e\u6027\u614b\u78bc\u70ba1(\u975e\u60e1\u6027)\u7684\u8840\u6db2\u816b\u7624\u7de8\u78bc\uff0c\u539fICD-O-3\u7121\u6b64\u985e\u7d44\u7e54\u578b\u614b\u78bc\uff0c\u50c5\u63d0\u4f9b\u53c3\u8003\u7528\uff0c\u8acb\u52ff\u7533\u5831<\/strong>\u3002<\/p>\n

(2) \u65b0\u589e\u7de8\u78bc9715\/3 Anaplstic large cell lymphoma, ALK-negative (\u539fICD-O-3\u7de8\u78bc\u70ba9702\/3)\u30019715\/3 Breast implant-associated anaplastic large cell lymphoma\u30019749\/3 Erdheim-Chester disease\u30019819\/3 B-lymphoblastic leukaemia\/lymphoma, BCR-ABL1-like\u30019877\/3 AML with mutated NPM1 (\u539fICD-O-3\u7de8\u78bc\u70ba9816\/3)\u30019878\/3 AML with biallelic mutation of CEBPA (\u539fICD-O-3\u7de8\u78bc\u70ba9816\/3)\u30019879\/3 AML with mutated RUNX1\u30019912\/3 AML with BCR-ABL1\u30019968\/3 Myeloid\/lymphoid neoplasms with PCM1-JAK2\u30019993\/3 Myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia\u3002<\/p>\n

(3) \u6027\u614b\u78bc3 (\u60e1\u6027)\u8b8a\u70ba1 (\u975e\u60e1\u6027)\u7684\u8840\u6db2\u816b\u7624\u7de8\u78bc\u5982\u4e0b\uff1a<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
WHO 2008<\/td>\nWHO 2017<\/td>\n<\/tr>\n
97093<\/td>\nCutaneous T-cell lymphoma, NOS (C44._)<\/td>\n97093<\/td>\nPrimary cutaneous acral CD8-positive T-cell lymphoma<\/td>\n<\/tr>\n
Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma<\/td>\nPrimary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma<\/td>\n<\/tr>\n
Primary cutaneous CD4-positive small\/medium T-cell lymphoma<\/td>\n97091<\/td>\nPrimary cutaneous CD4-positive small\/medium T-cell lymphoproliferative disorder<\/td>\n<\/tr>\n
97183<\/td>\nLymphomatoid papulosis (C44._)<\/td>\n97181<\/td>\nLymphomatoid papulosis (C44._)<\/td>\n<\/tr>\n
Primary cutaneous CD30-positive T-cell lymphoproliferative disorders (C44._)<\/td>\n97183<\/td>\nPrimary cutaneous CD30-positive T-cell lymphoproliferative disorders (C44._)<\/td>\n<\/tr>\n
Primary cutaneous anaplastic large cell lymphoma (C44._)<\/td>\nPrimary cutaneous anaplastic large cell lymphoma (C44._)<\/td>\n<\/tr>\n
97253<\/td>\nHydroa vacciniforme-like lymphoma<\/td>\n97251<\/td>\nHydroa vacciniforme-like lymphoproliferative disorder<\/td>\n<\/tr>\n
97513<\/td>\nLangerhans cell histiocytosis, NOS<\/td>\n97511<\/td>\nLangerhans cell histiocytosis, NOS<\/td>\n<\/tr>\n
Langerhans cell histiocytosis, mono-ostotic<\/td>\nLangerhans cell histiocytosis, monostotic<\/td>\n<\/tr>\n
Langerhans cell histiocytosis, poly-ostotic<\/td>\nLangerhans cell histiocytosis, polystotic<\/td>\n<\/tr>\n
Langerhans cell histiocytosis, disseminated<\/td>\n97513<\/td>\nLangerhans cell histiocytosis, disseminated<\/td>\n<\/tr>\n
99713<\/td>\nPolymorphic post-transplant lymphoproliferative disorder<\/td>\n99711<\/td>\nPolymorphic post-transplant lymphoproliferative disorder<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n
<\/div>\n

\u4e09\u3001 ICD-O-3\u7d44\u7e54\u578b\u614b\u7de8\u78bc\uff1a<\/p>\n

(1) \u65b0\u589e8801\/3-8804\/3 New term\uff0c\u5373Undifferentiated (\u672a\u5206\u5316) \u63cf\u8ff0\u3002<\/p>\n

(2) \u539f\u7de8\u78bc9871\/3 Acute myeloid leukemia, t(16;16)(p13;q11)\u6709\u8aa4\uff0c\u8acb\u4fee\u6b63\u70baAcute myeloid leukemia, t(16;16)(p13;q22)\u3002<\/p>\n

\u56db\u3001 \u4f9d\u764c\u767b\u4e2d\u5fc3\u8aee\u8a62\u75c5\u7406\u5c08\u5bb6\u610f\u898b\uff1a<\/p>\n

(1)\u4fee\u6b638830\/3 Undifferentiated high-grade pleomorphic sarcoma\u65bc\u539f\u767c\u90e8\u4f4d\u70baBONE\u9069\u7528\uff1b\u82e5\u767c\u751f\u65bc\u5176\u4ed6\u90e8\u4f4d\uff0c\u5247\u4ee58802\/3 Undifferentiated pleomorphic sarcoma\u7533\u5831\u3002<\/p>\n

(2)\u6709\u95dc\u60e1\u6027\u8166\u819c\u7624\u500b\u6848(M-code 953)\uff0c\u5176\u767c\u751f\u90e8\u4f4d\u61c9\u7de8\u78bc\u70ba\u8166\u819c(C70 Meminges)\u3002<\/p>\n

[\u764c\u767b\u7b2c107003\u865f\u901a\u77e5\u6587\u5168\u6587\u4e0b\u8f09<\/a>]<\/p>\n","protected":false},"excerpt":{"rendered":"

\u4e00\u3001 \u672c\u6848\u4fc2\u4f9d\u885b\u751f\u798f\u5229\u90e8\u570b\u6c11\u5065\u5eb7\u7f72\u59d4\u8a17\u300c … <\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17],"tags":[],"class_list":["post-2231","post","type-post","status-publish","format-standard","hentry","category-lastsnews"],"_links":{"self":[{"href":"https:\/\/twcr.tw\/index.php?rest_route=\/wp\/v2\/posts\/2231","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/twcr.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/twcr.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/twcr.tw\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/twcr.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2231"}],"version-history":[{"count":1,"href":"https:\/\/twcr.tw\/index.php?rest_route=\/wp\/v2\/posts\/2231\/revisions"}],"predecessor-version":[{"id":2236,"href":"https:\/\/twcr.tw\/index.php?rest_route=\/wp\/v2\/posts\/2231\/revisions\/2236"}],"wp:attachment":[{"href":"https:\/\/twcr.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2231"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/twcr.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2231"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/twcr.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2231"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}